Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy E Alphandery, S Faure, O Seksek, F Guyot, I Chebbi ACS nano 5 (8), 6279-6296, 2011 | 354 | 2011 |
Applications of magnetosomes synthesized by magnetotactic bacteria in medicine E Alphandéry Frontiers in bioengineering and biotechnology 2, 5, 2014 | 206 | 2014 |
Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic … E Alphandéry, F Guyot, I Chebbi International journal of pharmaceutics 434 (1-2), 444-452, 2012 | 143 | 2012 |
Iron oxide nanoparticles for therapeutic applications E Alphandéry Drug discovery today 25 (1), 141-149, 2020 | 132 | 2020 |
Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease E Alphandéry Nanotoxicology 13 (5), 573-596, 2019 | 129 | 2019 |
Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: A review E Alphandéry, I Chebbi, F Guyot, M Durand-Dubief International Journal of Hyperthermia 29 (8), 801-809, 2013 | 125 | 2013 |
Heat production by bacterial magnetosomes exposed to an oscillating magnetic field E Alphandéry, S Faure, L Raison, E Duguet, PA Howse, DA Bazylinski The Journal of Physical Chemistry C 115 (1), 18-22, 2011 | 124 | 2011 |
Glioblastoma treatments: an account of recent industrial developments E Alphandéry Frontiers in pharmacology 9, 879, 2018 | 118 | 2018 |
Assemblies of aligned magnetotactic bacteria and extracted magnetosomes: what is the main factor responsible for the magnetic anisotropy? E Alphandéry, Y Ding, AT Ngo, ZL Wang, LF Wu, MP Pileni Acs Nano 3 (6), 1539-1547, 2009 | 115 | 2009 |
Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma R Le Fèvre, M Durand-Dubief, I Chebbi, C Mandawala, F Lagroix, ... Theranostics 7 (18), 4618, 2017 | 113 | 2017 |
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects E Alphandéry, P Grand-Dewyse, R Lefèvre, C Mandawala, ... Expert Review of anticancer therapy 15 (10), 1233-1255, 2015 | 113 | 2015 |
Nano-therapies for glioblastoma treatment E Alphandéry Cancers 12 (1), 242, 2020 | 104 | 2020 |
Self-assembled InSb quantum dots grown on GaSb: A Photoluminescence, magnetoluminescence and atomic force microscopy study BZ E. Alphandéry, R. J. Nicholas, N. J. Mason, P. Möck, G. R. Booker Appl. Phys. Lett. 74, 2041, 1999 | 101 | 1999 |
Factors influencing the biosorption of gadolinium by micro-organisms and its mobilisation from sand Y Andres, G Thouand, M Boualam, M Mergeay Applied Microbiology and Biotechnology 54, 262-267, 2000 | 94 | 2000 |
Natural metallic nanoparticles for application in nano-oncology E Alphandéry International Journal of Molecular Sciences 21 (12), 4412, 2020 | 88 | 2020 |
Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using … E Alphandéry, A Idbaih, C Adam, JY Delattre, C Schmitt, F Guyot, I Chebbi Biomaterials 141, 210-222, 2017 | 84 | 2017 |
Bio-synthesized iron oxide nanoparticles for cancer treatment E Alphandéry International journal of pharmaceutics 586, 119472, 2020 | 73 | 2020 |
Perspectives of breast cancer thermotherapies E Alphandéry Journal of Cancer 5 (6), 472, 2014 | 68 | 2014 |
Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an … E Alphandéry, A Idbaih, C Adam, JY Delattre, C Schmitt, F Guyot, I Chebbi Journal of controlled release 262, 259-272, 2017 | 65 | 2017 |
Mass-dependent and-independent signature of Fe isotopes in magnetotactic bacteria M Amor, V Busigny, P Louvat, A Gélabert, P Cartigny, M Durand-Dubief, ... Science 352 (6286), 705-708, 2016 | 62 | 2016 |